Highlights:
- Close the Loop (ASX:CLG) grants Adamantem Capital an extended deadline until January 20, 2025, to finalize its due diligence.
- Adamantem’s proposed buyout offer of 27c per share values the e-waste recycling firm at $143 million, a significant premium to earlier trading levels.
- Shares climbed 7% during lunchtime trading, reflecting positive sentiment around the extended negotiations.
Close the Loop Ltd (ASX:CLG), a global player in e-waste recycling, has announced an extension for Adamantem Capital to complete its due diligence process for a proposed acquisition. Adamantem has until January 20, 2025, to finalize its decision, after which the deal will be terminated with no further extensions.
Adamantem previously made an offer to acquire Close the Loop for 27 cents per share, valuing the company at approximately $143 million. This offer came at a substantial premium compared to its earlier trading price of 17 cents per share, where the company's market capitalization stood at $90 million. Since the initial offer, Close the Loop’s share price has risen to 23 cents, suggesting growing optimism in the market regarding the deal.
The decision to extend due diligence follows a period of uncertainty despite earlier statements that the process was “materially complete.” While this could signal remaining complexities, the additional time indicates continued interest from Adamantem in finalizing the acquisition terms.
Shareholders responded positively to the news, with Close the Loop's stock climbing 7% during mid-day trading. This increase reflects investor confidence that the extension could lead to a favorable outcome.
The new deadline provides a clear timeframe for Adamantem to finalize its review. However, Close the Loop emphasized that if Adamantem fails to complete the process by January 20, 2025, the deal will be withdrawn permanently. The company’s firm stance ensures transparency and prevents prolonged negotiations.
Close the Loop’s international presence in the e-waste recycling sector and its strategic appeal appear to underpin the sustained interest from Adamantem. As the January deadline approaches, market attention will remain focused on whether Adamantem proceeds with its proposed acquisition at the stated premium.